BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 27144826)

  • 1. Imiquimod treatment effectively reduces the percentage of viable cells in a cervical carcinoma cell line but does not affect the expression of HLA-G or OCT-4.
    Stefanidis K; Patta J; Pergialiotis V; Stefanidi D; Loutradis D
    J Stem Cells; 2015; 10(4):217-23. PubMed ID: 27144826
    [TBL] [Abstract][Full Text] [Related]  

  • 2. C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro.
    Belcastro M; Miller MR; Flynn DC; Soisson AP
    Gynecol Oncol; 2004 Feb; 92(2):660-8. PubMed ID: 14766263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha?
    Urosevic M; Oberholzer PA; Maier T; Hafner J; Laine E; Slade H; Benninghoff B; Burg G; Dummer R
    Clin Cancer Res; 2004 Aug; 10(15):4959-70. PubMed ID: 15297396
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Topical imiquimod treatment for human papillomavirus infection in patients with and without cervical/vaginal intraepithelial neoplasia.
    Lin CT; Qiu JT; Wang CJ; Chang SD; Tang YH; Wu PJ; Jung SM; Huang CC; Chou HH; Jao MS; Lai CH
    Taiwan J Obstet Gynecol; 2012 Dec; 51(4):533-8. PubMed ID: 23276555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preliminary stop of the TOPical Imiquimod treatment of high-grade Cervical intraepithelial neoplasia (TOPIC) trial.
    Koeneman MM; Kruse AJ; Kooreman LF; Zur Hausen A; Hopman AH; Sep SJ; Van Gorp T; Slangen BF; van Beekhuizen HJ; van de Sande AJ; Gerestein CG; Nijman HW; Kruitwagen RF
    BMC Cancer; 2017 Feb; 17(1):110. PubMed ID: 28173776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Assessment of the treatment with imiquimod in persistent infection by human papillomavirus with the polimerase chain reaction method].
    Hernández Quijano T; Illanes Aguiar B; Salas Linares N; Alarcón Romero Ldel C; Hernández Valencia M
    Ginecol Obstet Mex; 2006 Jun; 74(6):317-26. PubMed ID: 16970118
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human leukocyte antigen-G (HLA-G) expression in cervical cancer lesions is associated with disease progression.
    Li XJ; Zhang X; Lin A; Ruan YY; Yan WH
    Hum Immunol; 2012 Sep; 73(9):946-9. PubMed ID: 22820627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toll-like receptor 7 agonist, imiquimod, inhibits oral squamous carcinoma cells through apoptosis and necrosis.
    Ahn MY; Kwon SM; Cheong HH; Park JH; Lee J; Min SK; Ahn SG; Yoon JH
    J Oral Pathol Med; 2012 Aug; 41(7):540-6. PubMed ID: 22577802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment.
    Urosevic M; Dummer R; Conrad C; Beyeler M; Laine E; Burg G; Gilliet M
    J Natl Cancer Inst; 2005 Aug; 97(15):1143-53. PubMed ID: 16077073
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical Therapy With Imiquimod for Vaginal Intraepithelial Neoplasia: A Case Series.
    Policiano AC; Lopes JP; Barata SA; Colaço AM; Calhaz-Jorge C
    J Low Genit Tract Dis; 2016 Jul; 20(3):e34-6. PubMed ID: 27158879
    [No Abstract]   [Full Text] [Related]  

  • 11. Treatment of vulvar intraepithelial neoplasia with topical imiquimod.
    van Seters M; van Beurden M; ten Kate FJ; Beckmann I; Ewing PC; Eijkemans MJ; Kagie MJ; Meijer CJ; Aaronson NK; Kleinjan A; Heijmans-Antonissen C; Zijlstra FJ; Burger MP; Helmerhorst TJ
    N Engl J Med; 2008 Apr; 358(14):1465-73. PubMed ID: 18385498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Impact of quercetin on the expression of heparanase in cervical cancer cells].
    Zhang WT; Zhang W; Zhong YJ; Lü QY; Cheng J
    Zhonghua Fu Chan Ke Za Zhi; 2013 Mar; 48(3):198-203. PubMed ID: 23849943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TLR7 Gln11Leu single nucleotide polymorphism and response to treatment with imiquimod in patients with basal cell carcinoma: a pilot study.
    Piaserico S; Michelotto A; Frigo AC; Alaibac M
    Pharmacogenomics; 2015 Nov; 16(17):1913-7. PubMed ID: 26556041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible erythropoietin signaling in squamous dysplasia and squamous cell carcinoma of the uterine cervix and its potential role in cervical carcinogenesis and tumor progression.
    Acs G; Zhang PJ; McGrath CM; Acs P; McBroom J; Mohyeldin A; Liu S; Lu H; Verma A
    Am J Pathol; 2003 Jun; 162(6):1789-806. PubMed ID: 12759237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topical application of imiquimod induces alterations in peripheral blood lymphocytes in healthy individuals.
    Pasmatzi E; Chaidaroglou A; Sakkis T; Monastirli A; Georgiou S; Sagriotis A; Badavanis G; Vryzaki E; Matsouka P; Degiannis D; Tsambaos D
    Acta Derm Venereol; 2009; 89(2):134-9. PubMed ID: 19325996
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression in actinic keratoses: pharmacological modulation by imiquimod.
    Lysa B; Tartler U; Wolf R; Arenberger P; Benninghoff B; Ruzicka T; Hengge UR; Walz M
    Br J Dermatol; 2004 Dec; 151(6):1150-9. PubMed ID: 15606509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imiquimod-induced clearance of HPV is associated with normalization of immune cell counts in usual type vulvar intraepithelial neoplasia.
    Terlou A; van Seters M; Kleinjan A; Heijmans-Antonissen C; Santegoets LA; Beckmann I; van Beurden M; Helmerhorst TJ; Blok LJ
    Int J Cancer; 2010 Dec; 127(12):2831-40. PubMed ID: 21351262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical imiquimod treatment prevents UV-light induced loss of contact hypersensitivity and immune tolerance.
    Thatcher TH; Luzina I; Fishelevich R; Tomai MA; Miller RL; Gaspari AA
    J Invest Dermatol; 2006 Apr; 126(4):821-31. PubMed ID: 16439962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New perspective in immunotherapy: local imiquimod treatment].
    Kemény L; Nagy N
    Orv Hetil; 2010 May; 151(19):774-83. PubMed ID: 20427260
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic anticancer activity of Thiazolo[5,4-b]quinoline derivative D3CLP in combination with cisplatin in human cervical cancer cells.
    González-Sánchez I; Lira-Rocha A; Navarrete A; Loza-Mejía MA; Coronel-Cruz C; Mendoza-Rodríguez CA; Cerbón MA
    Anticancer Res; 2012 Dec; 32(12):5159-65. PubMed ID: 23225412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.